The large T antigen exerts its transformational ability by binding to p53 and pRb of host cells, thereby inhibiting p53-dependent tumor-suppressive responses and abrogating pRb-dependent cell cycle arrest at G1/S transition [2]–[3]. This evidence concerns the gene TP53 and neoplasm.